GLOBUS MEDICAL INC (GMED) Stock
5 members of Congress disclosed 13 trades in GMED since 2015: 6 purchases and 7 sales, most recently Gilbert Cisneros (purchase, Sep 3, 2026). 6 of the hedge funds AlphaScala tracks reported GMED in 13F filings for the quarter ended Sep 30, 2026; the largest reported position is Bridgewater Associates's at $27.81M. Company insiders reported 0 open-market buys and 3 sales on SEC Form 4 in the 90 days to Nov 5, 2026.
Which members of Congress traded GLOBUS MEDICAL INC (GMED)?
Most recent: Gilbert Cisneros (purchase, Sep 3, 2026); records start Feb 13, 2015.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Gil Cisneros D-CA · House | 2026-09-03 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2026-08-19 | purchase | $15k – $50k |
| Gil Cisneros D-CA · House | 2026-03-03 | purchase | $1k – $15k |
| Lisa McClain R-MI · House | 2025-07-10 | sale | $1k – $15k |
| Lisa McClain R-MI · House | 2025-06-24 | partial sale | $1k – $15k |
| Lisa McClain R-MI · House | 2025-06-17 | purchase | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2025-04-09 | partial sale | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2023-04-03 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all GMED political trades →Which hedge funds own GMED?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Bridgewater Associates Ray Dalio | 352K | $27.81M | +7% |
| Renaissance Technologies Jim Simons (founder) | 197K | $15.56M | NEW |
| Marshall Wace | 189K | $14.90M | -66% |
| Hussman Investment Trust John Hussman | 53K | $3.93M | +25% |
| Millennium Management Israel Englander | 29K | $2.28M | -98% |
| D.E. Shaw David Shaw | 8K | $655.8K | -71% |
13F holdings as of Sep 30, 2026
Explore all tracked funds →Are GLOBUS MEDICAL INC insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Nov 4, 26 | Rhoads Ann D | Director | SELL | 5.0K | $425K |
| Sep 15, 26 | Tobin James R | Director | SELL | 30.0K | $2.2M |
| Aug 18, 26 | Zarrilli Stephen T | Director | SELL | 25.0K | $2.2M |
SEC Form 4 filings as of Nov 5, 2026
See cluster-buy signals across all tickers →GMED price chart
Powered by TradingViewWhat does GLOBUS MEDICAL INC do?
Globus Medical Inc. is a leading global musculoskeletal technology company that develops and commercializes implantable devices, biologics, accessories, and surgical instruments for spinal, orthopedic trauma, neurosurgical, and joint reconstruction procedures. The company focuses on solving unmet clinical needs through innovative solutions, including its comprehensive spine and orthopedic portfolios, regenerative biologics, and enabling technologies such as robotics, navigation systems, and the Excelsius™ platform. Globus Medical provides world-class education and clinical support via its Musculoskeletal Education and Research Center, offering training in cadaveric labs, research facilities with biomechanical testing, and peer-to-peer programs to advance patient outcomes. It emphasizes exceptional surgeon response, rapid product innovation through iterative design cycles, and collaboration with healthcare professionals to enhance surgical accuracy, minimize invasiveness, and improve care efficiency. Founded in 2003 and headquartered in Audubon, Pennsylvania, Globus Medical plays a vital role in the medical device industry by delivering technologies that promote healing for patients with musculoskeletal disorders.